Mitobulin Solution for Injection
Mitobulin Solution for Injection
Eribulin Mesylate (0.5mg/ml)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Mitobulin Solution for Injection, a concentrated solution of eribulin mesylate 0.5mg/mL, is a chemotherapeutic agent used in the treatment of locally advanced or metastatic breast cancer after failure of prior anthracycline-containing therapy. This solution for injection is a sterile, clear, colorless liquid that must be diluted with 0.9% sodium chloride or 5% dextrose solution before administration. Mitobulin works by inhibiting the polymerization of actin filaments, which is a critical component of the cytoskeleton in cancer cells, thereby disrupting cell morphology and inducing apoptosis. The recommended dose is 2mg/m2 administered intravenously over 2-5 minutes every 21 days. Patients should be pre-medicated with dexamethasone, diphenhydramine, and ranitidine or omeprazole to minimize the risk of hypersensitivity reactions. Mitobulin may cause serious side effects, including fatigue, nausea, vomiting, diarrhea, and myelosuppression, and patients should be monitored closely for these effects.
Active composition
Eribulin Mesylate
About Eribulin Mesylate
Eribulin Mesylate is an anti-cancer drug used to treat various malignancies, including breast cancer and liposarcoma. It works by inhibiting cancer cell division, effectively blocking tumor growth. Its significance in cancer therapy lies in its ability to manage advanced stages of these diseases. In summary, Eribulin Mesylate is essential for treating certain types of cancer.
How It Works
Eribulin Mesylate inhibits microtubule dynamics, preventing cancer cells from completing mitosis and thereby blocking tumor growth.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Mitobulin Solution for Injection. Please consult your doctor.
High Risk
Pregnancy
Mitobulin Solution for Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Mitobulin Solution for Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Mitobulin Solution for Injection should be used with caution in patients with liver disease. Dose adjustment of Mitobulin Solution for Injection may be needed. Please consult your doctor.
Regular Checkup
Breastfeeding
Mitobulin Solution for Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Mitobulin Solution for Injection should be used with caution in patients with kidney disease. Dose adjustment of Mitobulin Solution for Injection may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mitobulin Solution for Injection
Products matching your search
Megpro 160 Tablet
Megpro 160 Tablet
Femitraz Tablet
Femitraz Tablet
Megetra 40 Tablet
Megetra 40 Tablet
Zyceva 150 Tablet
Zyceva 150 Tablet
Letrovil 5 Tablet
Letrovil 5 Tablet
LETero Tablet
LETero Tablet
Eritel 20 Tablet
Eritel 20 Tablet
Megestrong 40 Tablet